✦ LIBER ✦

Toxicity of docetaxel plus cyclophosphamide as adjuvant therapy for breast cancer in Chinese patients – the Hong Kong experience

✍ Scribed by Tsz-Kok YAU; Ting-Ying NG; Inda Sung SOONG; Chi-Wai CHOI; Ka-On LAM; Alice Wan-Ying NG; Anne Wing-Mui LEE; Yuk TUNG

Book ID: 111318744
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 97 KB
Volume: 5
Category: Article
ISSN: 1743-7555
DOI: 10.1111/j.1743-7563.2009.01204.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III Trial Comparing Doxorubicin Pl

Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer

✍ Jones, S. E.; Savin, M. A.; Holmes, F. A.; O'Shaughnessy, J. A.; Blum, J. L.; Vu 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 372 KB

Toxicity of Dose-Dense Docetaxel Followe

Toxicity of Dose-Dense Docetaxel Followed by Doxorubicin with Cyclophosphamide as Adjuvant Therapy for Breast Cancer in a Phase II Study

✍ Rosemary Lambert-Falls; Susan Modugno 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 110 KB

The side effects of docetaxel with cyclo

The side effects of docetaxel with cyclophosphamide as postoperative adjuvant chemotherapy for elderly breast cancer patients

✍ Lingqin Song; Yinbin Zhang; Jianjun He; Xijing Wang; Hongbing Ma; Wentao Xi; Lia 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 221 KB

380 PUBLICATION The clinical outcome of

380 PUBLICATION The clinical outcome of 1034 Chinese patients after adjuvant therapies for female breast cancer, Hong Kong AR, China

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Estimation of the incidence of febrile n

Estimation of the incidence of febrile neutropenia in women receiving docetaxel plus cyclophosphamide as adjuvant therapy for early-stage breast cancer: a large community-based retrospective study

✍ Rodolfo Eduardo Bordoni; Sally Taylor Haislip; James Walter Gilmore Jr; Joyce Sh 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 236 KB

Cost–effectiveness analysis of adjuvant

Cost–effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)

✍ Sang Gyu Lee; Young Geon Jee; Hyun Chul Chung; Sung-Bae Kim; Jungsil Ro; Young-H 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 231 KB